AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31526964 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-course nutrition management from the Nutrition Support Team
Number of subjects: 96
Study 31526964 — intervention group
Group type: COMPARATOR
Intervention: General nutritional method (Control)
Number of subjects: 96
Study 30500754 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Linear Regression (MLR)
Number of subjects: 447
Study 30500754 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest Regression (RFR)
Number of subjects: 447
Study 30500754 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended MLR/RFR model
Number of subjects: 447
Study 30500754 — intervention group
Group type: COMPARATOR
Intervention: Intervention status
Number of subjects: 447
Study 28358852 — intervention group
Group type: EXPERIMENTAL
Intervention: Music training (MT group)
Number of subjects: 60
Study 28358852 — intervention group
Group type: COMPARATOR
Intervention: No music training (NMT group)
Number of subjects: 60
Study 25393158 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic Acid for Vascular Outcome Reduction in Transplant trial medication
Number of subjects: 4110
Study 25393158 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcineurin inhibitor and statin
Number of subjects: 4110
Study 25393158 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine and angiotensin-converting enzyme inhibitor
Number of subjects: 4110
Study 25393158 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfonylurea
Number of subjects: 4110
Study 25393158 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 4110
Study 23579523 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 100
Study 23579523 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 100
Study 23579523 — intervention group
Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 100
Study 19463994 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene
Number of subjects: 343
Study 19463994 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 343
Study 19463994 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene + Metformin
Number of subjects: 343
Study 19463994 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Modification
Number of subjects: 343
Study 18308881 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) - 30 maximal inspirations daily
Number of subjects: 16
Study 18308881 — intervention group
Group type: COMPARATOR
Intervention: Cardiovascular Training (CV) - 4 week program with three running sessions per week
Number of subjects: 16
Study 16669961 — intervention group
Group type: EXPERIMENTAL
Intervention: Oats
Number of subjects: 32
Study 16669961 — intervention group
Group type: COMPARATOR
Intervention: Gluten challenge
Number of subjects: 32
Study 16669961 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat-containing gluten-free diet
Number of subjects: 32
Study 12814443 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (10 mg)
Number of subjects: 16
Study 12814443 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 10772526 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymic transplantation
Number of subjects: 8
Study 10772526 — intervention group
Group type: COMPARATOR
Intervention: Control (no thymic transplantation)
Number of subjects: 8
Study 9193361 — intervention group
Group type: EXPERIMENTAL
Intervention: PIXY321 750 micrograms/m2/d divided into two subcutaneous doses
Number of subjects: 177
Study 9193361 — intervention group
Group type: COMPARATOR
Intervention: GM‐CSF 250 micrograms/m2/d as a 2‐hour intravenous infusion
Number of subjects: 177
Study 9193361 — intervention group
Group type: EXPERIMENTAL
Intervention: PIXY321
Number of subjects: 177
Study 9193361 — intervention group
Group type: COMPARATOR
Intervention: GM‐CSF
Number of subjects: 177
Study 1551960 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase support with a single dose of human chorionic gonadotrophin
Number of subjects: 30
Study 1551960 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful stimulation
Number of subjects: 30
Study 1551960 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor responders
Number of subjects: 30
Study 1551960 — intervention group
Group type: EXPERIMENTAL
Intervention: Early vascular maturation in the stroma
Number of subjects: 30
Study 3925179 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 86
Study 3925179 — intervention group
Group type: COMPARATOR
Intervention: No Heparin (Control)
Number of subjects: 86
Study 30418100 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill exercise training
Number of subjects: 184
Study 30418100 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 184
Study 30019627 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide 5 µg subcutaneously twice daily
Number of subjects: 528
Study 30019627 — intervention group
Group type: COMPARATOR
Intervention: Standard stroke unit care
Number of subjects: 528
Study 27054828 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness in schools curriculum (8 lessons, once weekly)
Number of subjects: 308
Study 27054828 — intervention group
Group type: COMPARATOR
Intervention: Normal lessons (control group)
Number of subjects: 308
Study 25175601 — intervention group
Group type: EXPERIMENTAL
Intervention: Incabotulinum toxin type A (iBTA) before conventional rehabilitation treatment (CT)
Number of subjects: 26
Study 25175601 — intervention group
Group type: COMPARATOR
Intervention: Saline before conventional rehabilitation treatment (CT)
Number of subjects: 26
Study 22923162 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT) + daily dietary supplement containing arginine, Vinitrox, collagen, methyl‐sulfonyl‐methane, vitamin C, and bromelain
Number of subjects: 0
Study 22923162 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21462480 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight reduction programme (dietary modifications of 1200-1400 kcal/day, physical activity modifications, behaviour therapy)
Number of subjects: 52
Study 21462480 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 healthy normal-weight children)
Number of subjects: 52
Study 17638555 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic nephrectomy
Number of subjects: 45
Study 17638555 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 45
Study 15931678 — intervention group
Group type: EXPERIMENTAL
Intervention: 902 MHz mobile phone exposure at 0.025 W
Number of subjects: 18
Study 15931678 — intervention group
Group type: EXPERIMENTAL
Intervention: 902 MHz mobile phone exposure at 0.25 W
Number of subjects: 18
Study 15931678 — intervention group
Group type: COMPARATOR
Intervention: Sham condition (0 W)
Number of subjects: 18
Study 12402722 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 40
Study 12402722 — intervention group
Group type: COMPARATOR
Intervention: 0.75% ropivacaine
Number of subjects: 40
Study 9986921 — intervention group
Group type: EXPERIMENTAL
Intervention: CRH administration during SWS (protocol A)
Number of subjects: 7
Study 9986921 — intervention group
Group type: EXPERIMENTAL
Intervention: CRH administration during wakefulness (protocols B and C)
Number of subjects: 7
Study 9986921 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH pre-treatment
Number of subjects: 7
Study 9986921 — intervention group
Group type: COMPARATOR
Intervention: Baseline condition (saline treatment only, protocol D)
Number of subjects: 7
Study 7569030 — intervention group
Group type: EXPERIMENTAL
Intervention: Three fractions per day (multiple fractions per day, MFD) with misonidazole 1 g/m2/day
Number of subjects: 523
Study 7569030 — intervention group
Group type: EXPERIMENTAL
Intervention: Three fractions per day (multiple fractions per day, MFD) without misonidazole
Number of subjects: 523
Study 7569030 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionation (70 Gy in 35 fractions, 7 weeks or 75 Gy in 44 fractions, 9 weeks)
Number of subjects: 523
Study 1887473 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone (100 mg) every 12 h for 6 weeks
Number of subjects: 120
Study 1887473 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets every 12 h for 6 weeks
Number of subjects: 120
Study 6415182 — intervention group
Group type: EXPERIMENTAL
Intervention: Formalin‐inactivated vaccine (doses not specified)
Number of subjects: 52
Study 6415182 — intervention group
Group type: EXPERIMENTAL
Intervention: Formalin‐inactivated vaccine
Number of subjects: 52
Study 6415182 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated controls
Number of subjects: 52
Study 31776684 — intervention group
Group type: EXPERIMENTAL
Intervention: FLS program
Number of subjects: 195
Study 31776684 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 195
Study 29807933 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartMate 3 (HM3)
Number of subjects: 366
Study 26731272 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting in a park
Number of subjects: 496
Study 26731272 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting in a cafe
Number of subjects: 496
Study 26731272 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking in a shopping mall
Number of subjects: 496
Study 26731272 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking along a busy street
Number of subjects: 496
Study 26731272 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentional fatigue
Number of subjects: 496
Study 26731272 — intervention group
Group type: EXPERIMENTAL
Intervention: Being with a close friend
Number of subjects: 496
Study 26731272 — intervention group
Group type: EXPERIMENTAL
Intervention: Alone
Number of subjects: 496
Study 25135724 — intervention group
Group type: EXPERIMENTAL
Intervention: Peg‐IFN alpha‐2b plus adefovir dipivoxil (10 mg daily) for 52 weeks
Number of subjects: 61
Study 25135724 — intervention group
Group type: COMPARATOR
Intervention: Peg‐IFN alpha‐2b alone (1.5 μg/kg once weekly) for 52 weeks
Number of subjects: 61
Study 22685578 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline (400 mg)
Number of subjects: 18
Study 22685578 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (300 mg)
Number of subjects: 18
Study 22685578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 22685578 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin (10 µg)
Number of subjects: 18
Study 20414559 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic education and protective footwear program (n=30)
Number of subjects: 53
Study 20414559 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=23)
Number of subjects: 53
Study 20414559 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=30)
Number of subjects: 53
Study 17915972 — intervention group
Group type: EXPERIMENTAL
Intervention: Family intervention approach according to the McMaster Model and maintenance of the anti‐depressant drug at the same dosage
Number of subjects: 20
Study 17915972 — intervention group
Group type: COMPARATOR
Intervention: Dose increase and clinical management
Number of subjects: 20
Study 16143228 — intervention group
Group type: COMPARATOR
Intervention: Calcium (500 mg elemental calcium, 400 IU Vitamin D3)
Number of subjects: 136
Study 16143228 — intervention group
Group type: COMPARATOR
Intervention: Raloxifene (60 mg/day)
Number of subjects: 136
Study 16143228 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen patches (3.9 mg estradiol) and progesterone (100 mg/day)
Number of subjects: 136
Study 16143228 — intervention group
Group type: COMPARATOR
Intervention: Calcium and Raloxifene (combined)
Number of subjects: 136
Study 16143228 — intervention group
Group type: COMPARATOR
Intervention: Raloxifene
Number of subjects: 136
Study 12709272 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human albumin (rHA), n = 43
Number of subjects: 85
Study 12709272 — intervention group
Group type: COMPARATOR
Intervention: Human serum albumin (HSA), n = 42
Number of subjects: 85
Study 10189539 — intervention group
Group type: EXPERIMENTAL
Intervention: Human ultralente (UL) insulin
Number of subjects: 178
Study 10189539 — intervention group
Group type: COMPARATOR
Intervention: Human NPH insulin
Number of subjects: 178
Study 10189539 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily NPH insulin
Number of subjects: 178
Study 8850573 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise (30 min of bench stepping at 15 steps min-1)
Number of subjects: 6
Study 8850573 — intervention group
Group type: COMPARATOR
Intervention: Concentric exercise (30 min of uphill walking at 5 km h-1, 8% incline)
Number of subjects: 6
Study 8850573 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling at 80% VO2 max for 15 min after eccentric exercise
Number of subjects: 6
Study 2407023 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin (400 mg tablet twice daily)
Number of subjects: 93
Study 2407023 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (double strength tablet twice daily)
Number of subjects: 93
Study 2407023 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 93
Study 2407023 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 93
Study 341944 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 25 mg
Number of subjects: 20
Study 341944 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin 10 mg
Number of subjects: 20
Study 341944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 341944 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 25 mg + Alcohol
Number of subjects: 20
Study 341944 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin 10 mg + Alcohol
Number of subjects: 20
Study 31783854 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic point-of-care reminders
Number of subjects: 328728
Study 31783854 — intervention group
Group type: COMPARATOR
Intervention: Monthly feedback
Number of subjects: 328728
Study 31783854 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for diabetic retinopathy
Number of subjects: 328728
Study 31783854 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of glycated hemoglobin
Number of subjects: 328728
Study 31783854 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation encouragement
Number of subjects: 328728
Study 28173780 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-administered intervention (6-month access)
Number of subjects: 200
Study 28173780 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual/waitlist (CAU/WL) control group
Number of subjects: 200
Study 25884350 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics administered within 1 hour before skin incision
Number of subjects: 464
Study 25884350 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic antibiotics administered after skin incision
Number of subjects: 464
Study 23986159 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol 0.005% (50 mcg/gm) applied twice a day
Number of subjects: 60
Study 23986159 — intervention group
Group type: COMPARATOR
Intervention: Coal tar 6% and salicylic acid 3% ointment applied at nighttime
Number of subjects: 60
Study 22390816 — intervention group
Group type: EXPERIMENTAL
Intervention: Alemtuzumab induction with tacrolimus monotherapy
Number of subjects: 0
Study 22390816 — intervention group
Group type: COMPARATOR
Intervention: Basiliximab induction with tacrolimus and mycophenolate mofetil (MMF) therapy
Number of subjects: 0
Study 19395556 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT device switched on
Number of subjects: 33
Study 19395556 — intervention group
Group type: COMPARATOR
Intervention: CRT device switched off
Number of subjects: 33
Study 17848796 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized aerobic exercise training combined with conventional spa therapy
Number of subjects: 44
Study 17848796 — intervention group
Group type: COMPARATOR
Intervention: Spa therapy alone
Number of subjects: 44
Study 14766772 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidants (all‐rac‐alpha‐tocopherol 800 mg/day for 3 weeks and alpha‐lipoic acid 600 mg/day for 2 weeks)
Number of subjects: 12
Study 14766772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 14766772 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidants
Number of subjects: 12
Study 11354934 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg daily for 13 weeks
Number of subjects: 501
Study 11354934 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine 20 mg daily, fluoxetine 90 mg weekly, or placebo during continuation therapy
Number of subjects: 501
Study 11354934 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation treatment (Fluoxetine 20 mg daily, fluoxetine 90 mg weekly)
Number of subjects: 501
Study 11354934 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (any dosage)
Number of subjects: 501
Study 11354934 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients reporting worsening sexual function
Number of subjects: 501
Study 11354934 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall sexual function
Number of subjects: 501
Study 9741610 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (3 supervised 45-min sessions per week for 12 weeks)
Number of subjects: 18
Study 9741610 — intervention group
Group type: COMPARATOR
Intervention: Contact control (3 health education lectures/discussions per week for 12 weeks)
Number of subjects: 18
Study 8150114 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin acetate (200 micrograms twice daily)
Number of subjects: 24
Study 8150114 — intervention group
Group type: COMPARATOR
Intervention: Leuprolide acetate (1 mg/d SC)
Number of subjects: 24
Study 3277925 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspartame
Number of subjects: 0
Study 3277925 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 0
Study 29380251 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40-mg every week (EW)
Number of subjects: 0
Study 29380251 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40-mg every other week (EOW)
Number of subjects: 0
Study 29380251 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab for non-dermatologic indications (including Crohn's disease, ulcerative colitis, and rheumatoid arthritis)
Number of subjects: 0
Study 27281802 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily snack made from leafy green vegetables, fruit, and milk
Number of subjects: 2291
Study 27281802 — intervention group
Group type: COMPARATOR
Intervention: Low-micronutrient vegetables (e.g., potato and onion)
Number of subjects: 2291
Study 27281802 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group (leafy green vegetables, fruit, and milk)
Number of subjects: 2291
Study 24103040 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n = 145)
Number of subjects: 253
Study 24103040 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 108)
Number of subjects: 253
Study 23904825 — intervention group
Group type: EXPERIMENTAL
Intervention: External tube drainage (ETD)
Number of subjects: 50
Study 23904825 — intervention group
Group type: COMPARATOR
Intervention: Omentoplasty (OP)
Number of subjects: 50
Study 20551163 — intervention group
Group type: EXPERIMENTAL
Intervention: Food color additive and sodium benzoate mixtures in a fruit drink (intervention group)
Number of subjects: 297
Study 20551163 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 297
Study 18503925 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous insulin infusion (CII)
Number of subjects: 200
Study 18503925 — intervention group
Group type: COMPARATOR
Intervention: Intermittent subcutaneous insulin therapy
Number of subjects: 200
Study 15567882 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel 0.75 mg given 24 h apart
Number of subjects: 2018
Study 15567882 — intervention group
Group type: COMPARATOR
Intervention: Levonorgestrel 0.75 mg given 12 h apart
Number of subjects: 2018
Study 12786681 — intervention group
Group type: EXPERIMENTAL
Intervention: Mydriatic digital photography
Number of subjects: 3611
Study 12786681 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-mydriatic digital photography
Number of subjects: 3611
Study 12786681 — intervention group
Group type: COMPARATOR
Intervention: Technician ophthalmoscopy
Number of subjects: 3611
Study 10225667 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory Muscle Stretch Gymnastics (RMSG)
Number of subjects: 16
Study 10225667 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragmatic Breathing (DB)
Number of subjects: 16
Study 8690809 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon
Number of subjects: 6
Study 8690809 — intervention group
Group type: EXPERIMENTAL
Intervention: High glucagon with insulin and GH
Number of subjects: 6
Study 8690809 — intervention group
Group type: EXPERIMENTAL
Intervention: AA infusion
Number of subjects: 6
Study 8690809 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of GH and insulin
Number of subjects: 6
Study 2009148 — intervention group
Group type: EXPERIMENTAL
Intervention: Delapril (15 mg single dose)
Number of subjects: 20
Study 2009148 — intervention group
Group type: COMPARATOR
Intervention: Captopril (18.75 mg single dose)
Number of subjects: 20
Study 2009148 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (2.5 mg single dose)
Number of subjects: 20
Study 2009148 — intervention group
Group type: EXPERIMENTAL
Intervention: Delapril (30 mg/day for 1 week)
Number of subjects: 20
Study 2009148 — intervention group
Group type: COMPARATOR
Intervention: Captopril (37.5 mg/day for 1 week)
Number of subjects: 20
Study 2009148 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (5 mg/day for 1 week)
Number of subjects: 20
Study 2009148 — intervention group
Group type: EXPERIMENTAL
Intervention: Delapril (4 weeks treatment)
Number of subjects: 20
Study 2009148 — intervention group
Group type: COMPARATOR
Intervention: Captopril (4 weeks treatment)
Number of subjects: 20
Study 2009148 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (4 weeks treatment)
Number of subjects: 20
Study 6800465 — intervention group
Group type: EXPERIMENTAL
Intervention: 1250 APTT units of low‐molecular‐weight heparin every 12 hours
Number of subjects: 150